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Covered Stents for
Coarctation of the Aorta
Treating the Interventionalist or the Patient?*
Ziyad M. Hijazi, MD, MPH,
Damien P. Kenny, MB, MD
Chicago, Illinois
Interventionalists treating congenital heart lesions are
constantly faced with challenging therapeutic decisions, often
without randomized trials to support one approach over the
other. Indeed, detailed outcome data, particularly outside
of the United States, may lag behind the availability of a
particular device or stent, and therefore, application of a
procedure may be based on rational thought and evolving
clinical experience rather than on published trials. This is
certainly the case with the use of covered stents for endo-
vascular treatment of coarctation of the aorta (CoA). Ther-
apeutic options for native CoA in adults have evolved from
surgical correction through balloon angioplasty in the early
1980s to stent implantation in the 1990s. Concerns regarding
the potential for aortic wall trauma with endovascular arte-
rioplasty evolved following reports describing high aneurysm
rates (7% to 20%) (1,2). Although reported rates of aortic wall
injury with stenting are signiﬁcantly lower (0% to 4%) (3–5),
scattered reports of aortic wall rupture following stentingSee page 416(6,7) have led to the perception that covered stents mitigate
against this, despite the fact that aortic wall disruption
following covered stent implantation has also been reported
(8,9). Therefore, outside of the United States and due to easy
availability, there is a move toward elective use of covered
stents for most aortic coarctation because of the perception
that this is safer for the patient. However, large studies
assessing the outcomes with bare-metal stents have demon-
strated excellent safety proﬁles. The largest of these studies
demonstrated aortic dissection in 9 of 565 procedures (1.6%)
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contents of this paper to disclose.signiﬁcantly more common in those who underwent pre-
stent balloon angioplasty (odds ratio [OR]: 4.2) and patients
over 40 years of age (OR: 2.95). A follow-up study from the
same group evaluating aneurysm formation with post-pro-
cedural imaging (albeit in only 27% of the cohort) conﬁrmed
the deleterious impact of pre-stent angioplasty (10). Age at
stent implantation in this study was not found to be signiﬁ-
cantly associated with aortic wall injury; however, abnor-
malities increased with a balloon/CoA ratio 3.5 (OR: 1.5).
More contemporary studies with complete follow-up imag-
ing have reported lower indexes of aortic wall injury (0% to
1%) (3,4). Recently, the COAST (Coarctation of the Aorta
Stent Trial) (11) reported on 105 patients with a median age
of 16 years who underwent implantation of a bare-metal
Cheatham-Platinum stent (NuMed Inc., Hopkinton, New
York) for native or recurrent coarctation through 19 centers
in the United States. Of 167 patients screened, 122 partici-
pants had a stent implanted, 17 (14%) of whom had a covered
stent (available under emergency use protocol) due to pre-
existing aortic wall injury, near atresia of the aorta, or phy-
sician preference. Indeed, 4 patients were found to have a
small aortic aneurysm after compliance testing with subse-
quent implantation of a covered stent, which raises further
questions about the risk/beneﬁt ratio of compliance testing
in this setting. Of the 105 bare-metal implants, 1 patient
(1%) developed a localized dissection after stenting that was
not seen with computed tomography the following day,
suggesting that the injury had healed. These studies support
the use of bare-metal stenting for the majority of patients
with CoA, with covered stents reserved for those deemed
to be high risk or with pre-existing aneurysm formation.
The deﬁnition of high risk is somewhat empiric but has
evolved from previous reports (5,8,10) and included older
patients (age >40 years), patients with Turner syndrome,
and those with near atresia of the aorta. Hence, variance
of opinion still exists with regard to the place for covered
stents in the setting of endovascular treatment of CoA
with the spectrum ranging from elective use in all patients
to bailout use with aortic wall injury following bare-metal
stenting.
In this issue of JACC: Cardiovascular Interventions, Soh-
rabi et al. (12) contribute signiﬁcantly to the debate
regarding choice of appropriate stent type in adult pati-
ents with native CoA. This is the ﬁrst randomized trial
addressing the use of bare and covered stents for the treat-
ment of CoA. They report acute and medium-term results
from 120 patients with a median age of 23.6 years, ran-
domized to receive either bare-metal or covered Cheatham-
Platinum stents. The majority of patients had severe CoA
with mean coarctation diameters of 3.3 mm in both cohorts
(similar measurements in COAST were 7.9 mm). The
protocol outlined an aggressive single-step dilation strategy
with no limitation placed in relation to balloon/CoA ratio
and a goal to achieve dilation up to the diameter of the
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425proximal isthmus at the level of the takeoff of the left sub-
clavian artery and not exceeding the aortic diameter at the
level of the diaphragm. Excellent procedural outcomes were
achieved in both groups with no major acute complications
including aortic wall compromise. Over a follow-up period
of 31 months, including high-resolution computed tomo-
graphic angiography assessment at 6 months in all patients,
pseudoaneurysm formation was noted in 2 patients, both in
the covered stent cohort. Both patients had elective suc-
cessful occlusion of these aneurysms with placement of
further covered stents. Recoarctation was noted in 4 pa-
tients; all were in the bare-metal stent cohort and all were
treated with further elective covered stent implantation,
although the reason for choosing a covered stent in this
setting is unclear and presumably related to concerns
regarding intimal ingrowth. These data support the pre-
existing literature demonstrating excellent therapeutic out-
comes with stenting for CoA. However, what conclusions
can be drawn regarding the need for covered stent implan-
tation? Elective covered stent implantation offered no
particular advantage in patients with severe native CoA, and
this is supported by numerous contemporary, albeit non-
randomized, studies reafﬁrming excellent outcomes with
minimal complication rates with bare-metal stents. One may
argue that covered stents may provide an “insurance policy”
against aortic dissection and rupture; however, this is not
supported by the albeit sparse literature, with 1 report
describing rupture following covered stent implantation for a
large aortic aneurysm (8). The investigators in this report
concluded that a self-expanding stent graft may have been
more appropriate, and this highlights the need for a sensible
application of available stent types to the varied anatomy
seen in CoA patients. Covered stents are an essential part of
the story, and the lack of wide availability in the United
States has limited choices for physicians and patients alike;
however, this should not translate into using them univer-
sally just because they are available. As many cases of stent
embolization have been reported as cases of severe aortic
wall trauma, and covered stent migration may be equally
catastrophic in this setting. Therefore, as interventionalists,
we should trust the data, and those who are fortunate
enough to have access to covered stents should use them
appropriately when potential beneﬁt is expected. To sum-
marize, we still believe that availability of covered stents is
important in the armamentarium of the interventional
cardiologist. We also believe, based on this study, that not
every case of CoA should have a covered stent implanted.Perhaps future studies should focus on identifying high-risk
groups that may truly beneﬁt from implantation of a covered
stent.
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